473927-64-9
中文名稱
6-(4-碘苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氫-1H-吡唑并[3,4-C]吡啶-3-羧酸乙酯
英文名稱
1-(4-Methoxyphenyl)-6-(4-iodophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester
CAS
473927-64-9
分子式
C22H20IN3O4
分子量
517.32
MOL 文件
473927-64-9.mol

基本信息
中文別名
阿哌沙班雜質(zhì)107(4-碘苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氫-1H-吡
6-(4-碘苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氫-1H-吡唑并[3,4-C]吡啶-3-羧酸
6-(4-碘苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氫-1H-吡唑并[3,4-C]吡啶-3-羧酸乙酯
6-(4-碘苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氫-1H-吡唑并[3,4-C]吡啶-3-羧酸乙酯,阿哌沙班中間體
6-(4-碘苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氫-1H-吡唑并[3,4-C]吡啶-3-羧酸乙酯,阿哌沙班中間體 10G
英文別名
Apixaban IVApixaban Impurity 107
AXN-IIIQ: What is AXN-III Q: What is the CAS Number of AXN-III
Ethyl 6-(4-iodophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine
ethyl 6-(4-iodophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxylate
Ethyl 6-(4-iodophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-
1-(4-Methoxyphenyl)-6-(4-iodophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxyli
6-(4-iodophenyl)-1-(4-Methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
Ethyl 6-(4-iodophenyl)-1-(4-methoxyphenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate
1-(4-Methoxyphenyl)-6-(4-iodophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl este
所屬類別
醫(yī)藥中間體:吡啶類化合物物理化學性質(zhì)
沸點649.4±55.0 °C(Predicted)
密度1.60
儲存條件2-8°C(protect from light)
酸度系數(shù)(pKa)-0.78±0.20(Predicted)
外觀Off-white to yellow Solid
制備方法
方法1

473927-69-4
![[(4-甲氧基苯基)肼基]氯乙酸乙酯](/CAS2/GIF/27143-07-3.gif)
27143-07-3
![6-(4-碘苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氫-1H-吡唑并[3,4-C]吡啶-3-羧酸乙酯](/CAS2/GIF/473927-64-9.gif)
473927-64-9
在惰性氣氛(氬氣)下進行反應。首先,將[(4-甲氧基苯基)亞肼基]氯乙酸乙酯(14.1 g, 0.055 mol)溶解于140 mL乙酸乙酯中。將溶液置于冰水浴中冷卻至0-5℃。在攪拌條件下,分批加入1-(4-碘苯基)-3-嗎啉-5,6-二氫吡啶-2(1H)-酮(21.1 g, 0.055 mol)。隨后,在0-5℃下緩慢滴加三乙胺(11.1 g, 0.110 mol)。停止冷卻,讓反應混合物升溫至室溫。接著,加熱反應混合物至回流狀態(tài),并維持回流約1小時。反應進程通過HPLC監(jiān)測,確保反應在120分鐘內(nèi)完成。再次將反應混合物冷卻至0-5℃,緩慢滴加由濃鹽酸(27.5 mL, 0.275 mol)與等體積蒸餾水稀釋的1:1鹽酸溶液。冷卻后,繼續(xù)攪拌反應混合物約1小時。然后,加入55 mL水,將形成的懸浮液在冷卻條件下繼續(xù)攪拌2小時。通過過濾分離產(chǎn)物,并在50℃下真空干燥24小時,得到6-(4-碘苯基)-1-(4-甲氧基苯基)-7-氧代-4,5,6,7-四氫-1H-吡唑并[3,4-c]吡啶-3-羧酸(產(chǎn)物III),產(chǎn)量21.3 g,產(chǎn)率75%,HPLC純度為95%。
參考文獻:
[1] Patent: WO2014/75648, 2014, A1. Location in patent: Page/Page column 11
[2] Patent: WO2015/177801, 2015, A1. Location in patent: Page/Page column 23